home / stock / alpn / alpn quote
Last: | $64.43 |
---|---|
Change Percent: | 0.06% |
Open: | $64.42 |
Close: | $64.43 |
High: | $64.48 |
Low: | $64.42 |
Volume: | 2,461,188 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$64.43 | $64.42 | $64.43 | $64.48 | $64.42 | 2,461,188 | 04-18-2024 |
$64.46 | $64.42 | $64.46 | $64.5 | $64.42 | 2,633,303 | 04-17-2024 |
$64.5 | $64.4 | $64.5 | $64.5 | $64.4 | 2,972,562 | 04-16-2024 |
$64.42 | $64.39 | $64.42 | $64.5 | $64.37 | 3,550,132 | 04-15-2024 |
$64.37 | $64.36 | $64.37 | $64.57 | $64.34 | 4,100,062 | 04-12-2024 |
$64.4 | $64.18 | $64.4 | $64.45 | $64.15 | 34,587,931 | 04-11-2024 |
$47.04 | $37.89 | $47.04 | $47.8399 | $37.431 | 12,234,018 | 04-10-2024 |
$38.94 | $39.16 | $38.94 | $39.63 | $37.57 | 1,174,762 | 04-09-2024 |
$38.53 | $34.83 | $38.53 | $39.5 | $34.25 | 2,587,463 | 04-08-2024 |
$34.91 | $35.14 | $34.91 | $36.13 | $34.51 | 1,099,932 | 04-05-2024 |
$35.33 | $38.35 | $35.33 | $38.42 | $34.31 | 1,578,520 | 04-04-2024 |
$38.11 | $39 | $38.11 | $40.14 | $36.66 | 1,647,247 | 04-03-2024 |
$39.21 | $39.72 | $39.21 | $41.16 | $39.01 | 1,005,298 | 04-02-2024 |
$40.22 | $39.31 | $40.22 | $40.32 | $37.93 | 1,355,370 | 04-01-2024 |
$39.64 | $38.65 | $39.64 | $41.04 | $37.18 | 1,462,110 | 03-29-2024 |
$39.64 | $38.65 | $39.64 | $41.04 | $37.18 | 1,462,110 | 03-28-2024 |
$38.65 | $37.7 | $38.65 | $39.04 | $36.68 | 787,120 | 03-27-2024 |
$37.45 | $37.86 | $37.45 | $39.15 | $37.42 | 776,940 | 03-26-2024 |
$37.55 | $39.3 | $37.55 | $40.1399 | $37.47 | 642,213 | 03-25-2024 |
$39.34 | $41.32 | $39.34 | $41.47 | $38.89 | 853,617 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Alpine Immune Sciences Inc. Company Name:
ALPN Stock Symbol:
NASDAQ Market:
Alpine Immune Sciences Inc. Website:
2024-04-18 08:30:00 ET Biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) continues to grab headlines. Over the past six months, the drugmaker has earned important regulatory approvals and made excellent clinical progress. But the company isn't stopping. Vertex just announced a mov...
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...
Alpine Immune Sciences, Inc. (NASDAQ: ALPN) is the focus of IBN's latest stock spotlight. The company's shares have moved 0.03% on the day to $64.44. Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherap...